Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line
1997
Combining Photodynamic Therapy with Mitomycin C for Bladder Cancer
publication
Evidence: moderate
Author Information
Author(s): SN Dattal, R Allman, C Loh, M Mason, PN Matthews
Primary Institution: University Hospital of Wales; Cancer Research Centre, Velindre Hospital
Hypothesis
Does photodynamic therapy enhance the effectiveness of mitomycin C in treating mitomycin-resistant bladder cancer cells?
Conclusion
Photodynamic therapy can enhance the effects of mitomycin C, even in mitomycin-resistant bladder cancer cells.
Supporting Evidence
- Mitomycin resistance does not confer resistance to photodynamic therapy.
- Mitomycin-resistant cells were more susceptible to photodynamic therapy than the parent cell line.
- Photodynamic therapy enhances the effect of mitomycin C when given first.
Takeaway
This study shows that a special light treatment can work better with a cancer drug, even when the cancer is resistant to that drug.
Methodology
The study involved treating bladder cancer cell lines with photodynamic therapy and mitomycin C, measuring cell survival through various assays.
Want to read the original?
Access the complete publication on the publisher's website